Skip to main content

Posts

Showing posts with the label single nucleotide polymorphism

Visualization of Mental Disorders by Molecular Connectivity with Omics Platform: A Short Review | Chapter 9 | New Frontiers in Medicine and Medical Research Vol. 13

According to new findings, a variety of environmental factors, including stressors, contribute to mental illness. Unmet medical outcomes and monitoring platforms in the field of mental illnesses currently necessitate the implementation of sensitivity associated with key biomarkers in the detection, evaluation, and validation processes. The use of omics in mental disorders and in a health care assessment platform, which is based on macromolecule dependent data analysis such as bioinformatics, has the potential to increase identification of risk genes and treatment options by validating functional efficacy of drugs or recovery status of brain function using behavioural assessment and metabolomics, which includes a neuro-pharmacogenomics study. This notion may appear futuristic, but it is great. If multiple data bases around the world continue to grow, increasing the likelihood of identifying a strand, health professionals such as clinicians and lab scientists will be able to predict the ...

Correlation of GSTP1 Polymorphism with Severity of Prostate Cancer in an Eastern Indian Population | Chapter 13 | Emerging Research in Medical Sciences Vol. 1

Background: GSTP1 is one of the Glutathione-S-Transferases (GSTs) which suppress tumor genesis by detoxifying toxic carcinogens and reactive oxygen species (ROS). Prostate cancer is related to several mutations affecting the expression of GSTP1. A single nucleotide polymorphism (SNP: Ile105Val) in the GSTP1 gene results insignificant reduction in its anticancer activity. The current case control study was conducted to ascertain the risk of association of GSTP1polymorphism with risk of cancer prostate in an Eastern Indian population. Materials and Methods: During a study period of 2 years, DNA was isolated using the phenol chloroform extraction method from the blood of 225 histopathologically diagnosed prostate cancer patients and 120 matched controls. The GSTP1 polymorphism was assessed by PCR amplification of the gene followed by restriction digestion with Alw261 (a restriction enzyme derived from Acinetobactro lwoffi RFL26). Histopathological grading in the case group was ...